Insider · CIK 0001583977
Cormorant Asset Management, LP
Files at EYPT (EyePoint Pharmaceuticals, Inc.), CRBP (Corbus Pharmaceuticals Holdings, Inc.), OKUR (OnKure Therapeutics, Inc.), AARD (Aardvark Therapeutics, Inc.), DRUG (BRIGHT MINDS BIOSCIENCES INC.). First filing Oct 17, 2024, latest Dec 15, 2025.
Where the trades landed
Last year at the 3 companies this insider has traded most, with each buy and sell on the bar it happened.
OKUR: OnKure Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
DRUG: BRIGHT MINDS BIOSCIENCES INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
CRBP: Corbus Pharmaceuticals Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | CRBPsell Corbus Pharmaceuticals Holdings, Inc. | $344k 30,029 shares | -1% | +97% from low-50% from high | |
| 40Moderate | EyePoint Pharmaceuticals, Inc. | $942k 60,000 shares | -1% | - | |
| 53Moderate | OKURsell OnKure Therapeutics, Inc. | $3.4M 1,813,439 shares | -100% | +13% from low-89% from high | |
| 19Weak | OKURsell OnKure Therapeutics, Inc. | $48k 24,300 shares | -1% | +2% from low-90% from high | |
| 54Moderate | Aardvark Therapeutics, Inc. | $3.0M 187,500 shares | +23% | - | |
| 43Moderate | DRUGbuy BRIGHT MINDS BIOSCIENCES INC. | $4.0M 184,331 shares | +21% | - | |
| 42Moderate | DRUGbuy BRIGHT MINDS BIOSCIENCES INC. | $3.2M 422,591 shares | +93% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | SOpen-market sale Common Stockindirect: See Footnotes | -30,029 | $11.46 | $344k | 2,344,971 | Dec 15, 2025 |
| Dec 4, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: See Footnotes | -60,000 | $15.70 | $942k | 8,265,000 | Dec 8, 2025 |
| May 15, 2025 | OKUR OnKure Therapeutics, Inc. | SOpen-market sale Class A Common Stockindirect: See Footnote | -1,813,439 | $1.85 | $3.4M | 0 | May 19, 2025 |
| May 12, 2025 | OKUR OnKure Therapeutics, Inc. | SOpen-market sale Class A Common Stockindirect: See Footnotes | -24,300 | $1.99 | $48k | 1,813,439 | May 14, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | CConversion Common Stockindirect: See Footnote | +800,189 | - | - | 800,189 | Feb 19, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +187,500 | $16.00 | $3.0M | 987,689 | Feb 19, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | CConversion Series C Convertible Preferred Stockderivativeindirect: See Footnotes | -6,780,810 | - | - | 0 | Feb 19, 2025 |
| Nov 4, 2024 | DRUG BRIGHT MINDS BIOSCIENCES INC. | POpen-market purchase Common Sharesindirect: See Footnote | +184,331 | $21.70 | $4.0M | 1,059,331 | Nov 6, 2024 |
| Oct 15, 2024 | DRUG BRIGHT MINDS BIOSCIENCES INC. | POpen-market purchase Common Sharesindirect: See Footnote | +238,097 | $4.53 | $1.1M | 690,506 | Oct 17, 2024 |
| Oct 15, 2024 | DRUG BRIGHT MINDS BIOSCIENCES INC. | POpen-market purchase Common Sharesindirect: See Footnote | +63,173 | $5.92 | $374k | 753,679 | Oct 17, 2024 |
| Oct 15, 2024 | DRUG BRIGHT MINDS BIOSCIENCES INC. | POpen-market purchase Common Sharesindirect: See Footnote | +33,343 | $6.42 | $214k | 787,022 | Oct 17, 2024 |
| Oct 15, 2024 | DRUG BRIGHT MINDS BIOSCIENCES INC. | POpen-market purchase Common Sharesindirect: See Footnote | +8,900 | $7.31 | $65k | 795,922 | Oct 17, 2024 |
| Oct 15, 2024 | DRUG BRIGHT MINDS BIOSCIENCES INC. | POpen-market purchase Common Sharesindirect: See Footnote | +2,600 | $8.80 | $23k | 798,522 | Oct 17, 2024 |
| Oct 15, 2024 | DRUG BRIGHT MINDS BIOSCIENCES INC. | POpen-market purchase Common Sharesindirect: See Footnote | +2,700 | $9.26 | $25k | 801,222 | Oct 17, 2024 |
| Oct 15, 2024 | DRUG BRIGHT MINDS BIOSCIENCES INC. | POpen-market purchase Common Sharesindirect: See Footnote | +19,169 | $11.72 | $225k | 820,391 | Oct 17, 2024 |
| Oct 15, 2024 | DRUG BRIGHT MINDS BIOSCIENCES INC. | POpen-market purchase Common Sharesindirect: See Footnote | +4,609 | $12.35 | $57k | 825,000 | Oct 17, 2024 |
| Oct 16, 2024 | DRUG BRIGHT MINDS BIOSCIENCES INC. | POpen-market purchase Common Sharesindirect: See Footnote | +39,743 | $23.22 | $923k | 864,743 | Oct 17, 2024 |
| Oct 16, 2024 | DRUG BRIGHT MINDS BIOSCIENCES INC. | POpen-market purchase Common Sharesindirect: See Footnote | +7,150 | $24.03 | $172k | 871,893 | Oct 17, 2024 |
| Oct 16, 2024 | DRUG BRIGHT MINDS BIOSCIENCES INC. | POpen-market purchase Common Sharesindirect: See Footnote | +3,107 | $25.22 | $78k | 875,000 | Oct 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.